Vidal, Gregory A <br/><br/>
Phase I Trial of Everolimus and Capecitabine in Metastatic HER2  [electronic resource] 

 -  Clinical breast cancer  10 2017 
 - 418-426 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1938-0666 
<br/><br/><label>Standard No.: </label>10.1016/j.clbc.2017.03.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Capecitabine--administration & dosage<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Everolimus--administration & dosage<br/>Female<br/>Humans<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Treatment Outcome